GSK Executives Admit Bribery and Tax Charges in China
A number of executives at the British drug maker GlaxoSmithKline have admitted to criminal charges of bribery and tax law violations, according to China's Public Security Bureau.
GSK's China Sales Staff Allegedly Bribed Doctors to Market Botox
Whistleblower says China-based sales staff allegedly handed doctors cash and other rewards to prescribe Botox
Blackstone and Lion Capital to Make Joint Bid for GSK's Lucozade and Ribena
Drug manufacturer GlaxoSmithKline to focus on health care segment.
Ex-Google Employee has Proof of UK Tax Avoidance
An ex-Google employee says the company's tax avoidance schemes are "smoke-screen to distort" where it carries out its business.
GlaxoSmithKline Accused of Market 'Abuse' over Antidepressant Drug
The OFT investigates whether or not any competition law has been infringed by the actions of GSK.
New Strain of Bird Flu Kills Two In China, Third Person Critical [VIDEO]
Two men die in Shanghai after contracting strain of avian influenza never passed to humans before.
Married Man Didier Jambart Became Gay Gambling Sex Addict After Taking GSK Parkinson’s Drug
GlaxoSmithKline ordered to pay €400,000 in damages to Jambert for side effects of Requip drug.
CERN and Science Budget Cuts Are Bad for EU Economic Recovery
The European Commission’s proposed across the board scientific budget cuts will hamper economic recovery by stagnating business and high skilled industries
Chengdu China Exclusive: Tax Breaks and Preferential Policies Push Western Investment
Chengdu officials reveal special treatment for Western companies looking for Chengdu headquarters.
GlaxoSmithKline to Acquire Human Genome in $2.8 bn Hostile Takeover
GSK expected to pay $14 per share for US biotechnology company in hostile takeover after earlier bid rejected.
Broken British Business: From Barclays to BP to Glaxo, UK Corporate Reputations are Suffering
Record fines, resignations, public apologies and embarrassing inquiries - just another week of tarnished reputations for British businesses
GlaxoSmithKline pleads guilty to £3bn fraud
UK pharmaceutical giant GlaxoSmithKline will plead guilty and pay a record breaking $3bn, to settle the largest case of healthcare fraud in US history.
GlaxoSmithKline Settles US Fraud Probe Case for $3bn [VIDEO]
GSK pleads guilty to misbranding Paxil and Wellbutrin and safety data omission on Avandia in record-breaking court settlement.
GSK Goes Hostile in $2.6bn Takeover Bid for Human Genome Sciences
GlaxoSmithKline, the British pharmaceutical company, will approach shareholders directly after the HGS board rejected its $2.6bn takeover bid.
GlaxoSmithKline Shares Drop at Weak First Quarter Results
Despite turnover and profits only seeing slight growth for GSK in the first quarter, the pharmaceutical giant still eyes a Human Genome Sciences takeover.
GlaxoSmithKline 'Disappointed' by Rejection of 'Fair' Bid for Human Genome Sciences
GSK offered $13 a share in an "unsolicited" bid for the US pharmaceutical company, but it was rejected as not being good enough.
GlaxoSmithKline Drug Studies See Progression for Type-2 Diabetes Treatment
The world's leading research-based pharmaceutical and healthcare company, GlaxoSmithKline has reported topline results from seven of the eight 'Harmony' Phase III studies investigating the use of albiglutide in type 2 diabetes.
GlaxoSmithKline Investing Over £500m in UK Factories After George Osborne's Tax Cuts
GSK said the chancellor's tax cut on medicine patents means they will build a new factory at Ulverston and invest more in their established sites.
GlaxoSmithKline Appeals Over Argentine Baby Drug Trial Fine
GSK Argentina Laboratories denies anti-pneumonia drug killed 14 babies and appeals against parental consent ruling.
GlaxoSmithKline shares down and a recommended hold on FTSE 100 ahead of Q2 results
Shares in pharmaceutical giant GlaxoSmithKline were down in afternoon trading on the FTSE 100 and are a recommended hold ahead of tomorrow's Q2 results announcement.
GlaxoSmithKline settles ‘Avandia’ litigation with £1.6bn; Shares rise on ‘resolution’
GlaxoSmithKline, has announced it is settling the “substantial majority” of claims against its ‘thiazolidinedione’ Avandia which was found to cause death in ‘heart failure’ patients after it was released to market.